LH

Labcorp Holdings Inc.

HealthcareMedical - Diagnostics & ResearchUSUSD

$260.06

+0.53%Live · FMPMay 29, 2026

Market cap

$21.32B

52w range

241.81 – 293.72

P / E

—

EPS

—

Volume

394.24K

Revenue · FY

$13.95B

+7.25% YoY

Stock splits

DB · stock_splits4

Date	Ratio	Type	Multiplier
Jul 03, 2023	291-for-250	Forward	1.16×
May 13, 2002	2-for-1	Forward	2.00×
Jun 12, 2001	2-for-1	Forward	2.00×
May 04, 2000	1-for-10	Reverse	0.10×

4DB · FMP /mergers-acquisitions

Whole-company transactions where LH is acquirer or target.

Date	Role	Counterparty	Filing
Nov 26, 2014	Acquirer	Cravath	SEC →
Apr 25, 1995	Acquirer	NantHealth, Inc.	SEC →
Mar 30, 1995	Acquirer	NantHealth, Inc.	SEC →
Mar 14, 1994	Acquirer	Rule	SEC →

DB · 13D/G4

Filed	Form	Reporter	% owned	Shares
Mar 27, 2023	—	Laboratory Corporation of America Holdings	9.80%	—	SEC →
Mar 09, 2022	—	(1) BlackRock, Inc.	10.40%	—	SEC →
Feb 10, 2022	—	The Vanguard Group - 23-1945930	11.24%	—	SEC →
Feb 01, 2022	—	(1) BlackRock, Inc.	8.60%	—	SEC →

Corporate actions combine splits (live, full history), symbol changes (refreshed weekly), the daily M&A wire, and 13D/G filings.